|
Features
|
Group 1 (n = 14)
|
Group 2 (n = 18)
|
p-value
|
|---|
|
Age, yearsb
|
33.0 ± 5.5
|
33.3 ± 3.3
|
0.8611
|
|
BMI, kg/m2b
|
22.4 ± 3.0
|
22.5 ± 2.6
|
0.9267
|
|
Endometrial polyps a
|
5 (35.7%)
|
2 (11.1%)
|
0.0948
|
|
Gravidityc
|
0 (0–1)
|
1 (0–2)
|
0.2706
|
|
Parityc
|
0 (0–0)
|
0 (0–0)
|
0.6622
|
|
Number of IVF cyclesc
|
0 (0–2)
|
1 (0–2)
|
0.4250
|
|
FSH, mIU/mLb
|
7.4 ± 2.8
|
7.8 ± 2.2
|
0.5781
|
|
AMH, ng/mL b
|
3.5 ± 3.0
|
4.1 ± 3.9
|
0.6377
|
|
Stimulation duration, daysb
|
8.9 ± 0.7
|
9.2 ± 1.3
|
0.5432
|
|
GT cumulative dose, IUb
|
1419.6 ± 371.6
|
1612.5 ± 532.3
|
0.2581
|
- BMI body mass index, FSH follicle-stimulating hormone, AMH anti-Mullerian hormone, GT gonadotropins
- a Data are presented as absolute numbers and %, χ2 test
- b Data are presented as mean ± standard deviation, t-test
- c Data are presented as medians (with interquartile range), Kruskal-Wallis test
